Skip to main content
Equibles
BKYI logo

BKYI · Bio Key International Inc · Metrics

Track BKYI — free

Use BKYI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BKYI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.74 +0.07 (+2.62%) At close · Sep 9
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As of the date of this report, the Company does not have enough cash for twelve months of operations. The history of losses, the negative cash flow from operations, and the dependence by the Company on its ability to obtain additional financing to fund its operations after the current cash resources are exhausted raises doubt about the Company's ability to continue as a going concern.”
View the 10-Q filed Aug 13, 2026
Market Cap
$3.84M
Shares
1.44M

BKYI metrics

55 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.74
Market cap
$3.84M

Price action

20 metrics
Price change (1W)
-11.3%
Price change (30D)
-36.0%
Price change (3M)
-37.5%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
126.4%
Annualized volatility (3M)
122.2%
Beta
—
RSI (14D)
28.1
Price vs SMA 50
-32.8%
Price vs SMA 200
—
Avg volume (3M)
79,179
Relative volume
0.2
Average dollar volume
$328,080

Company

3 metrics
Sector
Industrials
Industry
Security & Protection Services
Shares outstanding
1.44M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.6×
reciprocal yield 174.7%
P / book
0.9
reciprocal yield 113.0%
FCF yield
-108.6%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-157.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.0×
reciprocal yield 103.9%
EV / revenue historical average (5Y)
1.0×
reciprocal yield 103.9%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-14

Profitability

9 metrics
Gross margin
81.3%
Operating margin
-86.4%
Trailing 12 months
Net margin
-90.1%
Gross profit (TTM)
$5.45M
Operating profit (TTM)
−$5.79M
Net income (TTM)
−$6.04M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-62.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$45.07

Growth

11 metrics
Revenue growth YoY
+13.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$6.70M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+21.1%
Year over year · more shares
Revenue CAGR (3Y)
-5.4%
Revenue CAGR (5Y)
+15.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-139.2%
Return on assets
-80.7%
Debt / equity
—
Current ratio
1.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$4.16M
Quick ratio
1.1
Interest coverage
-108.4
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.38M
Total assets
$7.48M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$4.16M
Capital expenditures (TTM)
$5,964
R&D (TTM)
$2.64M
SG&A (TTM)
$6.10M
Stock compensation (TTM)
$918,799
R&D / revenue
39.3%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
0
13F filer change QoQ
-10
Institutional ownership
—

Short interest

3 metrics
Short interest
1.0%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
31 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1019034 CUSIP 09060C606 Visit website